EMA encourages tailored development of medicines for older people
EMA invites comments on reflection paper by 31 January 2018
The European Medicines Agency (EMA) is inviting comments from the public on a reflection paper on how medicine developers can better address the needs of older people who take medicines.
In general, older people are the highest users of medicines. According to Eurostat, they are expected to make up almost a third of all Europeans by 2050, and they take more medicines than the rest of the population. Yet, medicines are rarely developed or packaged to take into account their specific needs. For example, some older people can face challenges such as difficulty opening boxes or bottles, reading instructions, swallowing or breaking tablets and capsules, which can result in medicines not being taken as intended, medication errors and ultimately a reduced quality of life.
The reflection paper describes aspects that medicines developers may consider when designing medicines for older people, such as selecting appropriate routes of administration and dosage forms, dosing frequency, excipients, container closure systems, devices and technologies, and user instructions in the product information.
For example, when there is evidence that older people find it difficult to break a tablet by hand, companies may find ways to improve the breakability of the tablet or consider alternative administration approaches, such as small tablets in a dose dispenser. Similarly, companies may consider re-designing the containers so that older patients can open them easily without any assistance.
Comments are particularly invited on the accuracy of tablet breaking, the administration of medicines through feeding tubes, and on multiple compliance aids and multiple drug dispensing systems (containers that clearly state the name of the day or the moment when a medicine needs to be administrated).
Depending on the outcome of the public consultation, the content of the reflection paper might be further developed into regulatory or scientific guidance.
- Scientific guidelines: Need for a reflection paper on quality aspects of medicines for older people
- Medicines for older people
Latest News from
EESC urges Parliament and Council to swiftly adopt the Commission proposal on safeguarding competition in air transport19/01/2018 14:25:00
The EESC backs the EC’s proposal on the long-awaited revision of the regulation on safeguarding competition in air transport.
VAT: More flexibility on VAT rates, less red tape for small businesses19/01/2018 13:25:00
The proposals are the final steps of the EC’s overhaul of VAT rules, with the creation of a single EU VAT area to dramatically reduce the €50bn lost to VAT fraud each year in the EU, while supporting business and securing government revenues.
Mergers: EC approves Qualcomm's acquisition of NXP, subject to conditions19/01/2018 12:25:00
The EC has approved the proposed acquisition of NXP, based in the Netherlands, by Qualcomm of the US. The approval is conditional on full compliance with commitments offered by Qualcomm.
India joins Designview19/01/2018 11:25:00
As of 19 January 2018 the Indian Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) has made its design data available to the Designview search tool.